Credit Suisse’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $908K | Buy |
117,938
+2,794
| +2% | +$22.5K | ﹤0.01% | 2321 |
|
|
2023
Q4 | $1.01M | Buy |
115,144
+6,553
| +6% | +$48K | ﹤0.01% | 2324 |
|
|
2023
Q3 | $792K | Buy |
108,591
+21,072
| +24% | +$157K | ﹤0.01% | 2430 |
|
|
2023
Q2 | $579K | Buy |
87,519
+31,928
| +57% | +$163K | ﹤0.01% | 2700 |
|
|
2023
Q1 | $190K | Buy |
55,591
+7,112
| +15% | +$27.5K | ﹤0.01% | 3126 |
|
|
2022
Q4 | $135K | Sell |
48,479
-811
| -2% | -$2.42K | ﹤0.01% | 3275 |
|
|
2022
Q3 | $142K | Buy |
49,290
+638
| +1% | +$2.27K | ﹤0.01% | 3345 |
|
|
2022
Q2 | $169K | Sell |
48,652
-2,159
| -4% | -$8.45K | ﹤0.01% | 3388 |
|
|
2022
Q1 | $238K | Buy |
50,811
+1,108
| +2% | +$5.42K | ﹤0.01% | 3328 |
|
|
2021
Q4 | $301K | Buy |
49,703
+5,611
| +13% | +$39K | ﹤0.01% | 4112 |
|
|
2021
Q3 | $268K | Buy |
44,092
+5,978
| +16% | +$67.4K | ﹤0.01% | 4129 |
|
|
2021
Q2 | $477K | Buy |
+38,114
| New | +$413K | ﹤0.01% | 3873 |
|
|
2018
Q4 | – | Sell |
-85,261
| Closed | -$527K | – | 3957 |
|
|
2018
Q3 | $527K | Sell |
85,261
-1,329,848
| -94% | -$6.01M | ﹤0.01% | 3264 |
|
|
2018
Q2 | $9.04M | Sell |
1,415,109
-1,014,720
| -42% | -$7.22M | 0.01% | 1298 |
|
|
2018
Q1 | $16.9M | Buy |
2,429,829
+1,616,052
| +199% | +$18.8M | 0.02% | 954 |
|
|
2017
Q4 | $10.3M | Buy |
813,777
+671,437
| +472% | +$8.19M | 0.01% | 1268 |
|
|
2017
Q3 | $1.69M | Buy |
142,340
+47,379
| +50% | +$703K | ﹤0.01% | 2685 |
|
|
2017
Q2 | $1.42M | Sell |
94,961
-58,079
| -38% | -$775K | ﹤0.01% | 2460 |
|
|
2017
Q1 | $1.46M | Buy |
153,040
+19,454
| +15% | +$164K | ﹤0.01% | 2588 |
|
|
2016
Q4 | $1.18M | Sell |
133,586
-4,730
| -3% | -$42.5K | ﹤0.01% | 2887 |
|
|
2016
Q3 | $1.19M | Buy |
138,316
+41,501
| +43% | +$329K | ﹤0.01% | 2816 |
|
|
2016
Q2 | $773K | Buy |
96,815
+11,071
| +13% | +$86.1K | ﹤0.01% | 3145 |
|
|
2016
Q1 | $750K | Buy |
85,744
+33,115
| +63% | +$275K | ﹤0.01% | 2943 |
|
|
2015
Q4 | $493K | Sell |
52,629
-5,501
| -9% | -$47.7K | ﹤0.01% | 3395 |
|
|
2015
Q3 | $561K | Sell |
58,130
-259,386
| -82% | -$2.74M | ﹤0.01% | 3310 |
|
|
2015
Q2 | $3.68M | Buy |
317,516
+233,629
| +279% | +$2.4M | ﹤0.01% | 2011 |
|
|
2015
Q1 | $873K | Sell |
83,887
-5,121
| -6% | -$47.9K | ﹤0.01% | 3092 |
|
|
2014
Q4 | $1.03M | Buy |
89,008
+37,102
| +71% | +$366K | ﹤0.01% | 3119 |
|
|
2014
Q3 | $370K | Sell |
51,906
-45,517
| -47% | -$317K | ﹤0.01% | 3822 |
|
|
2014
Q2 | $691K | Buy |
97,423
+12,430
| +15% | +$72.8K | ﹤0.01% | 3594 |
|
|
2014
Q1 | $521K | Buy |
84,993
+21,947
| +35% | +$161K | ﹤0.01% | 3674 |
|
|
2013
Q4 | $551K | Buy |
63,046
+18,626
| +42% | +$114K | ﹤0.01% | 3713 |
|
|
2013
Q3 | $185K | Sell |
44,420
-47,072
| -51% | -$259K | ﹤0.01% | 3988 |
|
|
2013
Q2 | $646K | Buy |
+91,492
| New | +$639K | ﹤0.01% | 3124 |
|
Other funds holding MDXG
EWM
PCMI
TI
CC
Credit Suisse's MDXG Position: Q1 2024 in Review
Credit Suisse increased its MiMedx Group (MDXG) stake by 2.4% in Q1 2024, buying an estimated $22.5K and bringing the position to 117,938 shares worth $908K. The position accounts for ﹤0.01% of the portfolio, ranked #2321.
Credit Suisse first reported a position in MDXG in Q2 2013 and has held it in 34 quarters since. The position peaked at $16.9M in Q1 2018. 202 funds tracked by Wall St. Rank hold MDXG as of Q1 2024.
- Credit Suisse held 117,938 shares of MiMedx Group worth $908K as of Q1 2024.
- Credit Suisse bought 2,794 MiMedx Group shares in Q1 2024, an estimated $22.5K.
- MiMedx Group made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2321 holding.
- Credit Suisse first reported a position in MiMedx Group in Q2 2013 and has held it in 34 quarters since.
- Credit Suisse's MiMedx Group position peaked at $16.9M in Q1 2018.
- 202 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.